Back to search

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

Data up to Jan 2025

Published2000
Citations372
References24

Total Citations Per Year

Abstract

References (24)

The Development of a Menstrual Distress Questionnaire

1968 • 852 citations

Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons

1998 • 468 citations

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

1996 • 330 citations

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.

1995 • 224 citations

The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential

1996 • 204 citations

Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity

1995 • 182 citations

An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

2000 • 157 citations

The androgenicity of progestins

1995 • 126 citations

Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity

1995 • 123 citations

New progestogens in oral contraception

1994 • 114 citations

Dihydrospirorenone, a New Progestogen with Antimineralocorticoid Activity: Effects on Ovulation, Electrolyte Excretion, and the Renin-Aldosterone System in Normal Women

1991 • 107 citations

Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives

1984 • 102 citations

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

1995 • 101 citations

Dynamics of Suppression and Recovery of Plasma FSH, LH, Androstenedione and Testosterone in Polycystic Ovarian Disease Using an Oral Contraceptive

1974 • 87 citations

Update on oral contraceptive pills.

1999 • 70 citations

Attenuation of Mild Hyperandrogenic Activity in Postpubertal Acne by a Triphasic Oral Contraceptive Containing Low Doses of Ethynyl Estradiol and d,l-Norgestrel

1990 • 64 citations

Progestogens with antimineralocorticoid activity.

1985 • 62 citations

Dihydrospirorenone (ZK30595): A novel synthetic progestagen-characterization of binding to different receptor proteins

1992 • 60 citations

Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol

2000 • 47 citations

Synthesis and activities of anti-aldosterones

1983 • 21 citations

Isolation and identification of spirorenone metabolites from the monkey (Macaca fascicularis)

1982 • 10 citations

Influence of different progestogens on blood pressure of non-anaesthetized male spontaneously hypertensive rats

1992 • 7 citations

Advances in oral hormonal contraception.

1995 • 4 citations

Effects of drospirenone on blood pressure and heart rate in rats measured by highly sensitive radiotelemetry

1996 • 2 citations

Cited By (0)

Loading...